View in EDS

CodeBreak 200: study limitations, and future directions.

Saved in:
Bibliographic Details
Title: CodeBreak 200: study limitations, and future directions.
Authors: Alharbi M; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Awidi M; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Dy GK; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Source: Translational cancer research [Transl Cancer Res] 2024 Jan 31; Vol. 13 (1), pp. 15-21. Date of Electronic Publication: 2024 Jan 05.
Publication Type: Editorial; Comment
Journal Info: Publisher: Pioneer Bioscience Publishing Company Country of Publication: China NLM ID: 101585958 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2219-6803 (Electronic) Linking ISSN: 2218676X NLM ISO Abbreviation: Transl Cancer Res Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38410207
AccessLevel: 2
PubType: Editorial & Opinion
PubTypeId: editorialOpinion
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: CodeBreak 200: study limitations, and future directions.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Alharbi+M%22">Alharbi M</searchLink>; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.<br /><searchLink fieldCode="AU" term="%22Awidi+M%22">Awidi M</searchLink>; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.<br /><searchLink fieldCode="AU" term="%22Dy+GK%22">Dy GK</searchLink>; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101585958%22">Translational cancer research</searchLink> [Transl Cancer Res] 2024 Jan 31; Vol. 13 (1), pp. 15-21. <i>Date of Electronic Publication: </i>2024 Jan 05.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Editorial; Comment
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Pioneer+Bioscience+Publishing+Company%22">Pioneer Bioscience Publishing Company </searchLink><i>Country of Publication: </i>China <i>NLM ID: </i>101585958 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2219-6803 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222218676X%22">2218676X </searchLink><i>NLM ISO Abbreviation: </i>Transl Cancer Res <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38410207
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.21037/tcr-23-1477
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 15
    Titles:
      – TitleFull: CodeBreak 200: study limitations, and future directions.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Alharbi M
      – PersonEntity:
          Name:
            NameFull: Awidi M
      – PersonEntity:
          Name:
            NameFull: Dy GK
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 31
              M: 01
              Text: 2024 Jan 31
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2219-6803
          Numbering:
            – Type: volume
              Value: 13
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Translational cancer research
              Type: main
ResultId 1